Frazier Financial Advisors, LLC Astrazeneca PLC Transaction History
Frazier Financial Advisors, LLC
- $142 Billion
- Q2 2025
A detailed history of Frazier Financial Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Frazier Financial Advisors, LLC holds 892 shares of AZN stock, worth $67,203. This represents 0.04% of its overall portfolio holdings.
Number of Shares
892
Previous 762
17.06%
Holding current value
$67,203
Previous $56 Million
11.3%
% of portfolio
0.04%
Previous 0.04%
Shares
6 transactions
Others Institutions Holding AZN
# of Institutions
1,413Shares Held
506MCall Options Held
9.17MPut Options Held
3.07M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.3 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.1 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.68 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.4 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.37 Billion0.39% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $233B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...